对2型低喘的新目标
Quang Luu Quoc1,2, Youngwoo Choi3, Gyu-Young Hur4
1Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
The Korean journal of internal medicine
|February 5, 2024
概括
2型低喘 (T2L) 由于缺乏生物标志物,因此存在管理挑战. 本综述探讨了T2L特征和这种难以治疗的喘内型的潜在生物治疗方法.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 喘涉及呼吸道阻塞和炎症,造成诊断和治疗障碍.
- 末型分类,特别是分辨2型高 (T2H) 和2型低 (T2L) 喘的唾液形状,已经进步了理解和治疗.
- 虽然T2H喘已经看到了成功的生物疗法,T2L喘管理仍然具有挑战性,因为有限的生物标志物和不完全响应常规治疗.
研究的目的:
- 提供关于严重T2L喘的临床特征和潜在机制的见解.
- 研究T2L喘的潜在治疗策略,特别是生物治疗方法.
主要方法:
- 文献综述侧重于严重的T2L喘.
- 临床特征和炎症机制的分析.
- 探索当前和新兴的治疗方法.
主要成果:
- 与T2H喘相比,T2L喘具有明显的临床特征和炎症途径.
- 目前的抗炎疗法为T2L喘提供不完全的症状控制.
- 对于新型生物标志物和针对T2L喘的有针对性的生物疗法有着至关重要的需求.
结论:
- 严重的T2L喘需要进一步的研究来确定可靠的诊断生物标志物.
- 开发有效的生物治疗方法对于改善T2L喘的管理结果至关重要.
- 了解T2L机制是制定有针对性和有效的治疗干预措施的关键.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
300
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
300
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
298
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267
Asthma: Pathogenesis and Management
403
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
403


